20112023

Research activity per year

Network

L Tonneijck

Person: Academic

Etto Eringa

Person: Academic

Emma Bouman

Person: Academic

Jaap A. Joles

  • University Medical Center Utrecht
  • Utrecht University

External person

A. H. Jan Danser

  • Erasmus University Medical Center
  • Erasmus MC University Medical Center

External person

Jaap A. Joles

  • Utrecht University

External person

Djuna L. Cahen

  • Erasmus Universiteit Rotterdam
  • Amstelland Hospital

External person

Frits A.J. Muskiet

  • University Medical Center Groningen
  • University of Groningen
  • Sint Elisabeth Hospitaal

External person

Karuna E W Vendrik

  • VU University Medical Center
  • Leiden University
  • National Institute of Public Health and the Environment
  • Vrije Universiteit Amsterdam

External person

Petter Bjornstad

  • University of Colorado Denver

External person

Hiddo J. L. Heerspink

  • UMCG/RU Groningen
  • The George Institute for Global Health
  • University of Groningen

External person

R. S. Kuipers

  • University of Groningen

External person

Hiddo J. Lambers Heerspink

  • University Medical Center Groningen

External person

Frank Geurts

  • Division of Nephrology and Transplantation, Rotterdam, Netherlands

External person

D. Margriet Ouwens

  • Heinrich Heine University Duesseldorf
  • German Center for Diabetes Research
  • Ghent University

External person

Indra C. Pieters

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Rosa M. Bent

  • Vrije Universiteit Amsterdam

External person

Ann Hammarstedt

  • AstraZeneca Sweden

External person

K. Melissa Hallow

  • University of Georgia

External person

Yehuda Handelsman

  • Metabolic Institute of America, 91356 Tarzana, United States

External person

Suvanjaa Sivalingam

  • Novo Nordisk A/S

External person

Danique Ruiter

  • From the Department of Cardiology (G.A.d.W., Amsterdam, Netherlands
  • University of Amsterdam

External person

Lars Jorge Diaz

  • Novo Nordisk A/S

External person

Yao Huang

  • Sanofi, Bridgewater, United States

External person

Danii L.S. Suijk

  • VU Medisch Centrum

External person

A H Jan Danser

  • Erasmus Universiteit Rotterdam

External person

F. A. J. Muskiet

  • University Medical Center Groningen

External person

Peter J. Greasley

  • AstraZeneca Sweden

External person

Charles J. Blijdorp

  • Erasmus Universiteit Rotterdam

External person

Mark H H Kramer

  • Section Acute Medicine
  • VU University Medical Centre

External person

I. G. Pranger

  • University Medical Center Groningen

External person

M. F. Luxwolda

  • University of Groningen

External person

Minzhi Liu

  • Sanofi, Bridgewater, United States

External person

David C. Wheeler

  • University College London

External person

Piet M. Ter Wee

  • VU University Medical Centre
  • Department of Nephrology

External person

D. Margriet Ouwens

  • German Diabetes Center Düsseldorf
  • German Center for Diabetes Research (DZD), Muenchen-Neuherberg, Germany
  • Ghent University

External person

Kasper A. Overbeek

  • Erasmus Universiteit Rotterdam

External person

Trine Henriksen

  • University of Copenhagen

External person

Jens J. Holst

  • University of Copenhagen

External person

Andrea Bozovic

  • Department of Clinical Biochemistry, Toronto, Canada
  • Department of Laboratory Medicine and Pathobiology, Toronto, Canada

External person

Aramesh Saremi

  • Sanofi, Bridgewater, United States

External person

Mark H.H. Kramer

  • University of Amsterdam
  • Amsterdam University Medical Centers

External person

J.D.A. Dijck-Brouwer

  • University of Groningen

External person

A. H. J. Danser

  • Erasmus Universiteit Rotterdam

External person

Graydon S. Meneilly

  • Department of Medicine, V5Z1M9 Vancouver, Canada

External person

Jordan Kraaijenhof

  • University of Amsterdam

External person

Daan M. Van Velzen

  • University of Amsterdam
  • Northwest Clinics

External person

Henrik E. Poulsen

  • Department of Clinical Pharmacology, Copenhagen, Denmark
  • Department of Clinical Medicine, Copenhagen, Denmark

External person

Adrian Post

  • University of Groningen

External person

Marco J Bruno

  • Erasmus University Medical Center
  • Erasmus MC University Medical Center
  • Erasmus Universiteit Rotterdam

External person

Emil L. Larsen

  • Department of Clinical Pharmacology, Copenhagen, Denmark

External person

Henrik Enghusen Poulsen

  • University of Copenhagen

External person

Jaap A Joles

  • Utrecht University
  • Department of Nephrology and Hypertension

External person

Ele Ferrannini

  • University of Pisa

External person

A. Mari

  • National Research Council of Italy
  • Mathematical Modeling and Website Management
  • Coordinating Office

External person

Niki Arya

  • Bio Pharmaceuticals R&D, Astra Zeneca, Gaithersburg, MD

External person

J. de Graaf

  • Radboud University Nijmegen
  • University of Groningen

External person

I. P. Kema

  • University Medical Center Groningen

External person

Emilie Hein Zobel

  • Novo Nordisk A/S

External person

Natalie Nokoff

  • University of Colorado Denver

External person

A. H. Jan Danser

  • Medical Center Haaglanden

External person

Cecilia Karlsson

  • AstraZeneca Sweden

External person